Awards

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award. 
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

THE RECIPIENTS ARE: . . .

ISPOR BEST POSTER RESEARCH PRESENTATION AWARDS

Best General Poster Research Presentations

PPM9: PARTICIPANT SCREENING BEHAVIORS AND INFORMATION SHARING AFTER GENETIC TESTING

Presenting Author: Adriana Boateng-Kuffour, MS, MPH.

Boateng-Kuffour A1, Zimmer A1, Chua A2, Lai C1, Ryan L1, Williams H1, Zhou A1

1Color, Burlingame, CA, USA, 2California State University, Stanislaus, Turlock, CA, USA

 

PCV30: ESTIMATING HEALTH-STATE UTILITY IN PATIENTS WITH HEART FAILURE: MAPPING THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE TO SF-6D UTILITY SCORES

Presenting Author: Scott Goates, PhD, MS

Goates S1, Baron SJ2, Arnold SV3, Prillinger JB4, Cohen D5, Spertus JA6
1Abbott Laboratories, CASTAIC, CA, USA, 2Saint Luke’s Mid America Heart Institute, Kansas City, MO, USA, 3Saint Luke's Mid America Heart Institute, Kansas City, MO, USA, 4Abbott Laboratories, Sunnyvale, CA, USA, 5Saint Luke’s Mid America Heart Institute/University of Missouri Kansas City School of Medicine, Kansas City, MO, USA, 6Saint Luke's Mid America Heart Institute/UMKC, Kansas City, MO, USA

 

PIH62: ELAGOLIX REDUCES WORK PRODUCTIVITY LOSSES AMONG WOMEN WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH ENDOMETRIOSIS

Presenting Author: Ahmed M Soliman, MS, PhD

Surrey ES1Soliman AM2, Palac H3, Agarwal SK4
1Colorado Center for Reproductive Medicine, Lone Tree, CO, USA, 2AbbVie, North Chicago, MA, USA, 3AbbVie Inc., North Chicago, IL, USA, 4Center for Endometriosis Research and Treatment, La Jolla, CA, USA

 

Best Student Poster Research Presentations

PMH49: FACILITY AND STATE-LEVEL FACTORS ASSOCIATED WITH TELEMENTAL HEALTH (TMH) ADOPTION AMONG MENTAL HEALTH FACILITIES IN THE UNITED STATES (US)

Presenting Author: Xiaohui Zhao, MS

Zhao X1, Bhattacharjee S2, Innes K3, LeMasters T4, Dwibedi N4, Sambamoorthi U4
1West Virginia University, School of Pharmacy, Boston, MA, USA, 2University of Arizona, Tucson, AZ, USA, 3West Virginia University, Morgantown, WV, USA, 4West Virginia University, School of Pharmacy, Morgantown, WV, USA

 

PCV102: HEALTH RELATED QUALITY OF LIFE OF STROKE SURVIVORS COMPARED TO NON-STROKE INDIVIDUALS AMONG AFRICAN AMERICANS IN THE UNITED STATES: A NATIONALLY REPRESENTATIVE PROPENSITY SCORE MATCHED ANALYSIS

Presenting Author: Arun Kumar, B.Pharm, Pharm.D, MS, PhD Student

Kumar A1, Wu W2
1College of Pharmacy, University of Minnesota, Minneapolis, MN, USA, 2College of Pharmacy and Health Sciences, St. John's University, New York, NY, USA

 

PRO40: ASSOCIATION BETWEEN HYDROXYUREA MEDICATION ADHERENCE AND ALL-CAUSE AND DISEASE-RELATED HEALTHCARE EXPENDITURES AMONG TEXAS MEDICAID ENROLLEES WITH SICKLE CELL DISEASE

Presenting Author: Hyeun Ah Kang, MS, MEd, PhD Candidate

Kang HA1, Barner JC1, Rascati K1, Lawson KA1, Mignacca R2
1The University of Texas at Austin, Austin, TX, USA, 2Dell Children’s Blood and Cancer Center, Austin, TX, USA

Best New Investigator Poster Research Presentations

PCV105: EXAMINING THRESHOLDS FOR THE RENIN-ANGIOTENSIN SYSTEM ANTAGONIST MEDICATION ADHERENCE QUALITY MEASURE: THE APPLICATION OF THE LAW OF DIMINISHING RETURNS TO OPTIMIZE ADHERENCE-ASSOCIATED ECONOMIC OUTCOMES

Presenting Author: Patrick J Campbell, PharmD, PhD

Campbell P1, Malone D2, Slack M2, Hincapie A3, Warholak T2
1Pharmacy Quality Alliance, Alexandria, VA, USA, 2University of Arizona, Tucson, AZ, USA, 3University of Cincinnati, Cincinnati, OH, USA

 

PPM4: COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION SEQUENCING PANEL OF CIRCULATING TUMOR DNA IN THE DIAGNOSIS OF PATIENT WITH METASTATIC NON-SQUAMOUS NON- SMALL CELL LUNG CANCER IN BRAZIL

Presenting Author: Rodrigo Ho, B Pharm

Ho R1, Sebastião MM2, D'Innocenzo M2, Nussbaum M2
1Roche Diagnostics Brazil, S PAULO, SP, Brazil, 2Roche Diagnostics Brazil, São Paulo, Brazil

 

PCV74: COST REDUCTION AFTER THE INDUCTION OF THE RESIDENT ENLIGHTMENT BASED ON MEDICAL CHECKUP IN A JAPANESE RURAL AREA

Presenting Author: Ayako Shoji, Ph.D

Shoji A1, Kudo K2, Murashita K2, Nakaji S2, Igarashi A3
1University of Tokyo, Saitama, 11, Japan, 2Hirosaki University, 5 Zaifucho, Japan, 3University of Tokyo, Tokyo, Japan

Best Podium - General Poster Research Presentations

DM3: QUANTIFYING THE OPPORTUNITY TO REDUCE TOTAL COST OF CARE THROUGH TARGETED MEDICATION PRIORITIZATION AND ADHERENCE IMPROVEMENT IN DIABETES

Presenting Author: Sebastian Schneeweiss, MD, ScD

Schneeweiss S1, Eapen S2, Jan S3
1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, 2Aetion, Inc, Boston, MA, USA, 3Horizon Blue Cross Blue Shield, Newark, NJ, USA

 

ND2: COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT

Presenting Author: Daniel Malone, RPh, PhD

Malone D1, Dean R2, Miller B2, Arjunji R3, Feltner DE3, Sproule DM3, Jensen IS2, Maru B3, Dabbous O3
1University of Arizona, Tucson, AZ, USA, 2Precision Xtract, Boston, MA, USA, 3AveXis, Inc., Bannockburn, IL, USA

AD3: FOOD INSECURE CANCER SURVIVORS ARE MORE LIKELY TO FORGO OR DELAY MEDICAL CARE

Presenting Author: Jean Mcdougall, PhD

Mcdougall J, Anderson J, Adler Jaffe S, Dailey Y, Meisner A, Sussman A, Guest D, Wiggins C
University of New Mexico, Albuquerque, NM, USA

Best Podium - Student Poster Research Presentations

IN4: REDUCING HOSPITAL-ONSET CLOSTRIDIUM DIFFICILE INFECTION: AN AGENT-BASED MODELING APPROACH TO EVALUATE INTERVENTION COST-EFFECTIVENESS

Presenting Author: Oguz Alagoz, PhD

Barker A1, Scaria E1, Safdar N2Alagoz O3
1University of Wisconsin, Madison, WI, USA, 2William S. Middleton Memorial Veterans Hospital, Madison, WI, USA, 3University of Wisconsin, Middleton, WI, USA

 

ON1: UNDERSTANDING VARIATION IN TREATMENT SEQUENCES AND OUTCOMES IN METASTATIC COLORECTAL CANCER: USING REAL WORLD DATA TO ANSWER REAL WORLD QUESTIONS

Presenting Author: Koen Degeling, MSc

Wong HL1Degeling K2, Jalali A1, Shapiro J3, Kosmider S4, Wong R5, Lee B1, Burge M6, Tie J1, Yip D7, Nott L8, Khattak A9, Lim S10, Caird S11, IJzerman M12, Gibbs P1
1Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, 2University of Twente, Enschede, Netherlands, 3Cabrini Health, Malvern, VIC, Australia, 4Western Health, Footscray, VIC, Australia, 5Walter and Eliza Hall Institute of Medical Research, Box Hill, Australia, 6Royal Brisbane and Women’s Hospital,, South Brisbane, QLD, Australia, 7The Canberra Hospital, Garran, ACT, Australia, 8Royal Hobart Hospital, Hobart, TAS, Australia, 9FIona Stanley Hospital, Murdoch, Australia, 10Campbelltown Hospital, Campbelltown, NSW, Australia, 11Gold Coast University Hospital, Southport, QLD, Australia, 12University of Melbourne, Melbourne, VIC, Australia

 

TP3: FACTORS ASSOCIATED WITH PRESCRIBING OF ORAL DISEASE MODIFYING AGENTS IN MULTIPLE SCLEROSIS

Presenting Author: Jagadeswara Rao Earla, PharmD, MBA

Earla JR1, Hutton GJ2, Thornton JD1, Aparasu R1
1University of Houston, Houston, TX, USA, 2Baylor College of Medicine Medical Center, McNair Campus, Houston, TX, USA


Best Podium - New Investigator Poster Research Presentations

AD4: THE IMPACT OF MEDICARE STAR RATING ADHERENCE MEASURES ON MEDICATION ADHERENCE FOR TARGETED AND NON-TARGETED MEDICATIONS

Presenting Author: Natasha Parekh, MD, MS

Parekh N1, Munshi K2, Hernandez I3, Gellad WF4, Henderson R2, Shrank WH5
1UPMC Center for High-Value Health Care, Pittsburgh, PA, USA, 2Express Scripts, Memphis, TN, USA, 3University of Pittsburgh, Pittsburgh, PA, USA, 4Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA, 5UPMC Insurance Services Division, Pittsburgh, PA, USA

MS3: NEW METHODOLOGIES IN PARAMETRIC NETWORK META-ANALYSES (PNMA): MULTI-ARM CORRECTION FOR RANDOM EFFECTS AND GENERAL POPULATION MORTALITY (GPM)

Presenting Author: Sophie van Beekhuizen, MSc MPhil

van Beekhuizen S1, van Oostrum I1, Ouwens DM2, Heeg B1
1Ingress-Health, Rotterdam, Netherlands, 2AstraZeneca, Mölndal, Sweden

MT4: COST UTILITY ANALYSIS UPDATE OF DEEP BRAIN STIMULATION VS. BEST MEDICAL TREATMENT IN THE MANAGEMENT OF PARKINSON DISEASE WITH EARLY MOTOR COMPLICATIONS IN COLOMBIA

Presenting Author: Julian Arcos, BME, MSc, HE

Rueda M1Arcos J2, Tellez J3, Valencia J4
1Clinica Soma, Medellin, Colombia, 2Medtronic Colombia, Bogota, Colombia, 3Medtronic Colombia, BOGOTA, CUN, Colombia, 4Medtronic, Miami, FL, USA